MedTrace Logo

Intravenous Tramadol Versus Intravenous Paracetamol in Patients With Dysmenorrhea

NCT03509740 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-06-16

No results posted yet for this study

Summary

Patients presented with primary dysmenorrhea composed the study population. One gram paracetamol and 100 mg tramadol in 100 ml saline with a slow infusion were compared in ceasing dysmenorrhea in the emergency department

Conditions

  • Dysmenorrhea

Interventions

DRUG

tramadol

100 mg tramadol in 100 ml saline with slow infusion

DRUG

paracetamol

Intravenous 1 gm paracetamol in 100 ml saline with slow infusion

Sponsors & Collaborators

  • Algazeerah hospital

    collaborator UNKNOWN

  • Cairo University

    lead OTHER

Principal Investigators

  • AHMED SAMY, MD · Cairo University

  • mahmoud alalfy, MD · National Research Center

  • Ahmed Ali, mbbch · faculty of medicine al-azhar university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-25
Primary Completion
2018-10-01
Completion
2018-10-20

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03509740 on ClinicalTrials.gov